Microfluidics platform for studies of peptide - polyelectrolyte interaction.

Drug In vitro method Microfluidics Microgel Peptide Polyelectrolyte Protein Subcutaneous administration

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
10 Jun 2022
Historique:
received: 26 01 2022
revised: 12 04 2022
accepted: 26 04 2022
pubmed: 3 5 2022
medline: 7 6 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Subcutaneous injection is one of the most common approaches for administering biopharmaceuticals unsuitable for oral delivery. However, there is a lack of methods to predict the behavior of biopharmaceuticals within the extracellular matrix of the subcutaneous tissue. In this work, we present a novel miniaturized microfluidic-based in vitro method able to investigate interactions between drug molecules and the polymers of the subcutaneous extracellular matrix. To validate the method, microgels consisting of, respectively, covalently cross-linked hyaluronic acid, polyacrylic acid, and commercially available DC Bead™, were exposed to three model substances: cytochrome C, protamine sulfate and amitriptyline hydrochloride. These components were chosen to include systems with widely different physiochemical properties (charge, size, self-assembly, etc.) The experimental results were compared with theoretical predictions from a gel model developed earlier. The results show that the method is suitable as a rapid screening method for automated, large-scale, probing of interactions between biopolymers and drug molecules, with small consumption of material.

Identifiants

pubmed: 35500690
pii: S0378-5173(22)00340-4
doi: 10.1016/j.ijpharm.2022.121785
pii:
doi:

Substances chimiques

Biological Products 0
Microgels 0
Peptides 0
Polyelectrolytes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121785

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Auteurs

Marcus Wanselius (M)

Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden.

Sean Searle (S)

Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden.

Agnes Rodler (A)

Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden.

Maria Tenje (M)

Department of Material Science and Engineering, Science for Life Laboratory, Uppsala University, P.O. Box 35, SE-751 03 Uppsala, Sweden.

Susanna Abrahmsén-Alami (S)

Innovation Strategies & External Liaison. Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.

Per Hansson (P)

Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden. Electronic address: per.hansson@ilk.uu.se.

Articles similaires

Animals Huntington Disease Mitochondria Neurons Mice
Animals Adjuvants, Immunologic Mice Antigen-Presenting Cells Antigen Presentation
Hemolysin Proteins Artificial Cells Protein Engineering Protein Transport Cell Membrane
Substrate Specificity Peptides Catalysis Hydrolysis Protein Conformation

Classifications MeSH